Health TrialsbyHealthPanel

Metaphor-Based Smoking Cessation Intervention

ConditionsSmoking CessationMobile Health
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBeijing Normal University

About this trial

This study aims to evaluate the effectiveness and participant experiences of a WeChat-delivered, metaphor-based smoking cessation intervention.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

aged 18 and above, reside in Zhuhai for the next 6 months;

smoke at least 1 cigarette or use e-cigarettes daily;

Having a smartphone and a WeChat account, being able to use WeChat skillfully.

Disqualifiers

Smokers who have communication barrier (either physically or cognitively);

Smokers who are currently participating in other SC programmes or services

Trial design

Design model

Parallel

Treatments tested in this trial

  • Metaphor-based smoking cessation intervention

    Behavioral

    Participants will receive a 100-day, WeChat-delivered smoking cessation intervention using metaphors such as "fog" and "restart" to describe smoking urges, nicotine dependence, and the process of behavior change. The intervention will provide staged messages on smoking-trigger identification, self-monitoring, action planning, coping strategies, environmental modification, social support, and relapse prevention, together with personalized feedback and a personalized journey map to help participants review their cessation experiences and progress.

  • 5A's/5R's advice

    Behavioral

    The 5A's approach (Ask, Advise, Assess, Assist, and Arrange) will be used for participants who are ready to quit, and the 5R's approach (Relevance, Risks, Rewards, Roadblocks, and Repetition) will be used for participants who are not ready to quit.

  • Health warning leaflet

    Other intervention

    The health warning leaflet provides essential information on the dangers of secondhand and thirdhand smoke. It outlines how exposure to these forms of smoke can harm both smokers and non-smokers, particularly children, by increasing the risk of respiratory illnesses and other health issues.

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: Metaphor-based intervention groupExperimental treatment 3 interventions
Group B: Control groupActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

Biochemical validated quit rate at 6 months follow-up

The primary outcomes are biochemically validated quit rate (exhaled carbon monoxide \< 4 ppm or salivary cotinine \< 30 ng/ml)

Time frame
6 months follow-up

Secondary outcomes

1

Biochemical validated quit rate at 3 months follow-up

biochemically validated quit rate (exhaled carbon monoxide \< 4 ppm or salivary cotinine \< 30 ng/ml)

Time frame
3 months follow-up
2

Self-reported 7-day point prevalence quit rate

Self-reported 7-day point prevalence quit rate in the two groups

Time frame
3 and 6 months follow-up
3

Smoking reduction rate

Rate of smoking reduction by at least half of baseline amount in the two groups

Time frame
3 and 6 months follow-up
4

Eligibility rate

the percentage of eligible smokers out of the total number of smokers screened

Time frame
baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Beijing Normal University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: